Clear and present data: identifying barriers to clinical trial transparency
What’s standing in the way of researchers adopting good practices on clinical trial data sharing and transparency?
Reporting of many clinical trials ruled illegal
A US court ruling finds reporting of many clinical trials of unapproved drugs in breach of the law. But responses to the ruling are uncertain.
Less than half of US clinical trials report results on ClinicalTrials.gov on time
Less than half of trials on clinicaltrials.gov meet the FDAAA results reporting deadline in a study from Ben Goldacre’s EBM DataLab at Oxford University
Can holding institution heads to account lead to improved rates of clinical trial reporting?
AllTrials seeks support for a new initiative to monitor clinical trial reporting in the UK.
Meeting report: summary of day 1 of the 2019 European ISMPP Meeting
Missed ISMPP EU 2019? Read our meeting report to get up to speed!
Clinical trial transparency: are non-commercial funders lagging behind industry sponsors?
A new study from the AllTrials team sheds light on clinical trial reporting rates by non-industry sponsors.
A new series from The BMJ highlights unreported trials
A new, regular series in The BMJ will highlight a different unreported clinical trial every week, with the intention of improving reporting rates.
What proportion of clinical trial data is reported? TrialsTracker launches new monitoring tool
The FDAAA 2007 requires clinical trials to make results publicly available 12 months after study completion. A new tool from TrialsTracker provides a live online report on compliance.